PMGC Holdings Inc. is a management, advisory, and investment company specializing in United States (U.S.)-based opportunities across financial services, manufacturing, and healthcare. The Company's portfolio consists of various subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., PMGC Capital LLC, and AGA Precision Systems LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. AGA Precision Systems LLC specializes in CNC machining operations.
BörsenkürzelELAB
Name des UnternehmensPMGC Holdings Inc
IPO-datumNov 21, 2023
CEOBensler (Graydon)
Anzahl der mitarbeiter2
WertpapierartOrdinary Share
GeschäftsjahresendeNov 21
Addresse120 Newport Center Drive
StadtNEWPORT BEACH
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92660
Telefon18884454886
Websitehttps://pmgcholdings.com/
BörsenkürzelELAB
IPO-datumNov 21, 2023
CEOBensler (Graydon)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten